Basic Information
| LncRNA/CircRNA Name | CCAT1 |
| Synonyms | NA |
| Region | NA |
| Ensemble | ENSG00000247844 |
| Refseq | NR_108049 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | Colorectal Cancer |
| ICD-0-3 | C19.9 |
| Methods | qPCR |
| Sample | blood |
| Expression Pattern | up-regulated |
| Function Description | The results showed that the expression of MALAT1, CCAT1, and PANDAR was significantly upregulated with 1.86, 4.54, and 4.68-fold increased levels ( p < 0.05), respectively, in the blood of CRC patients compared to the controls. However, the other lncRNAs examined were not significantly expressed in CRC blood samples. |
| Pubmed ID | 31328973 |
| Year | 2019 |
| Title | Long Noncoding RNAs as Prognostic Markers for Colorectal Cancer in Saudi Patients |
External Links
| Links for CCAT1 | GenBank HGNC NONCODE |
| Links for Colorectal Cancer | OMIM COSMIC |